1 unknown, 1 withdrawn. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 1, Withdrawn 1 |
| Phase 3 | 2 | Unknown 1, Withdrawn 1 |
Follow Heavy Metal Poisoning: new trials by email Literature Review of Heavy Metal Poisoning trials Research Report on Heavy Metal Poisoning
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| NBMI Treatment in Patients With Mercury Toxicity (N1, N3-bis(2- mercaptoethyl)isophthalamide), Excipients microcrystalline cellulose, silica and magnesium stearate - Mercury Poisoning | Phase 2 / Phase 3 | Unknown | EmeraMed | 116 | 2023-11-22 | 2024-03-12 |
| Penicillamine Chelation for Children With Lead Poisoning d-penicillamine, placebo - Lead Poisoning, Vitamin D Deficiency | Phase 2 / Phase 3 | Withdrawn | FDA Office of Orphan Products Development | 2007-09-01 | 2015-03-26 |
Lead Poisoning (1) · Mercury Poisoning (1) · Vitamin D Deficiency (1)
Chemically-Induced Disorders (2) · Poisoning (2) · Avitaminosis (1) · Deficiency Diseases (1) · Malnutrition (1) · Nutrition Disorders (1) · Nutritional and Metabolic Diseases (1)
Silicon Dioxide (1) · stearic acid (1)
EmeraMed (1) · FDA Office of Orphan Products Development (1)
Colombia (1) · United States (1)